Jacobi Capital Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $465K | Buy |
2,106
+83
| +4% | +$23K | 0.02% | 465 |
|
|
2026
Q1 | $598K | Sell |
2,023
-39
| -2% | -$11.6K | 0.03% | 378 |
|
|
2025
Q4 | $563K | Buy |
2,062
+28
| +1% | +$7.61K | 0.03% | 383 |
|
|
2025
Q3 | $550K | Buy |
2,034
+21
| +1% | +$5.71K | 0.03% | 375 |
|
|
2025
Q2 | $555K | Sell |
2,013
-170
| -8% | -$46.2K | 0.04% | 357 |
|
|
2025
Q1 | $579K | Buy |
2,183
+14
| +0.6% | +$3.45K | 0.04% | 332 |
|
|
2024
Q4 | $504K | Sell |
2,169
-99
| -4% | -$22.8K | 0.04% | 346 |
|
|
2024
Q3 | $500K | Buy |
+2,268
| New | +$469K | 0.04% | 350 |
|
|
2024
Q2 | – | Sell |
-955
| Closed | -$206K | – | 517 |
|
|
2024
Q1 | $206K | Buy |
955
+4
| +0.4% | +$840 | 0.02% | 459 |
|
|
2023
Q4 | $200K | Buy |
+951
| New | +$203K | 0.02% | 453 |
|
|
2022
Q3 | – | Sell |
-1,053
| Closed | -$216K | – | 402 |
|
|
2022
Q2 | $216K | Hold |
1,053
| – | – | 0.03% | 380 |
|
|
2022
Q1 | $250K | Sell |
1,053
-3
| -0.3% | -$705 | 0.03% | 370 |
|
|
2021
Q4 | $241K | Sell |
1,056
-77
| -7% | -$16.9K | 0.03% | 384 |
|
|
2021
Q3 | $219K | Buy |
1,133
+5
| +0.4% | +$1.01K | 0.03% | 382 |
|
|
2021
Q2 | $240K | Buy |
1,128
+17
| +2% | +$3.59K | 0.03% | 344 |
|
|
2021
Q1 | $227K | Sell |
1,111
-60
| -5% | -$11.8K | 0.03% | 326 |
|
|
2020
Q4 | $213K | Buy |
1,171
+164
| +16% | +$27.9K | 0.03% | 309 |
|
|
2020
Q3 | $168K | Hold |
1,007
| – | – | 0.03% | 317 |
|
|
2020
Q2 | $164K | Sell |
1,007
-7
| -0.7% | -$1.25K | 0.03% | 309 |
|
|
2020
Q1 | $175K | Hold |
1,014
| – | – | 0.04% | 268 |
|
|
2019
Q4 | $204K | Hold |
1,014
| – | – | 0.04% | 287 |
|
|
2019
Q3 | $214K | Sell |
1,014
-33
| -3% | -$6.89K | 0.04% | 267 |
|
|
2019
Q2 | $203K | Sell |
1,047
-143
| -12% | -$26.4K | 0.04% | 274 |
|
|
2019
Q1 | $196K | Sell |
1,190
-103
| -8% | -$18.2K | 0.05% | 230 |
|
|
2018
Q4 | $243K | Sell |
1,293
-118
| -8% | -$21.8K | 0.07% | 194 |
|
|
2018
Q3 | $240K | Sell |
1,411
-726
| -34% | -$122K | 0.06% | 190 |
|
|
2018
Q2 | $350K | Buy |
2,137
+558
| +35% | +$91.1K | 0.1% | 128 |
|
|
2018
Q1 | $249K | Buy |
+1,579
| New | +$251K | 0.07% | 150 |
|
|
2016
Q4 | – | Sell |
-59
| Closed | -$6K | – | 625 |
|
|
2016
Q3 | $6K | Hold |
59
| – | – | ﹤0.01% | 531 |
|
|
2016
Q2 | $6K | Buy |
+59
| New | +$5.58K | ﹤0.01% | 518 |
|
Other funds holding CME
Jacobi Capital Management's CME Position: Q2 2026 in Review
Jacobi Capital Management increased its CME Group (CME) stake by 4.1% in Q2 2026, buying an estimated $23K and bringing the position to 2,106 shares worth $465K. The position accounts for 0.02% of the portfolio, ranked #465.
Jacobi Capital Management first reported a position in CME in Q2 2016 and has held it in 30 quarters since. The position peaked at $598K in Q1 2026. 1,705 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Jacobi Capital Management held 2,106 shares of CME Group worth $465K as of Q2 2026.
- Jacobi Capital Management bought 83 CME Group shares in Q2 2026, an estimated $23K.
- CME Group made up 0.02% of Jacobi Capital Management's portfolio in Q2 2026, its #465 holding.
- Jacobi Capital Management first reported a position in CME Group in Q2 2016 and has held it in 30 quarters since.
- Jacobi Capital Management's CME Group position peaked at $598K in Q1 2026.
- 1,705 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Jacobi Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.